Patients around the country are enrolling in clinical trials, choosing to partner with researchers to help their fellow patients and have a chance at the latest treatment approaches. Since several large cancer centers joined together to form the Blood and Marrow Transplant Clinical Research Network (BMT CTN) in 2001, several studies have provided results that help patients today receive better care. Two physicians at the center of this research are Dr. Sergio Giralt, of Memorial Sloan Kettering Cancer Center, and Dr. Philip McCarthy, of Roswell Park Cancer Institute. In this interview, recorded at the American Blood and Marrow Transplantation’s 2014 BMT Tandem Meeting in Grapevine, Texas, Drs. Giralt and McCarthy underscore why this research is so important, reminding patients that the “treatment you’re getting today is because people participated in trials previously, and you’re developing the modern treatments of tomorrow.”

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…